For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Zhi Luo

USPTO Granted Patents = 17 (Patent Applications = 4)

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

Nanjing, CN (2021)
Shanghai, CN (2020 - 2024)

Company Filing History:

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Yangtze River Pharmaceutical Group Co., Ltd.

Zhuhai United Laboratories Co., Ltd.

4. 3 out of 118

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd.

Zhongshan Ophthalmic Center, Sun Yat-sen University

Medshine Discovery Inc.

Shandong Danhong Pharmaceutical Co., Ltd.

9. 2 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12479823 - Compound for use in retinal diseases (2025-11-25),

2. 12473258 - Crystal form of pyridinylphenyl compound and preparation method therefor (2025-11-18),

3. 12329763 - Composition of lanosterol prodrug compound, preparation method therefor and use thereof (2025-06-17),

4. 12077513 - Process route of compound of formula (IV), crystal form and preparation method therefor (2024-09-03),

5. 11932617 - Compound for use in retinal diseases (2024-03-19),

6. 11753377 - Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound (2023-09-12),

7. 11667667 - Steroid derivative FXR agonist (2023-06-06),

8. 11505532 - SSAO inhibitor (2022-11-22),

9. 11149055 - Crystal form of lanosterol prodrug compound and application thereof (2021-10-19),

10. 11001563 - SSAO inhibitor (2021-05-11),

11. 10981860 - Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof (2021-04-20),

12. 10912775 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2021-02-09),

13. 10898486 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2021-01-26),

14. 10875888 - Steroid derivative FXR agonist (2020-12-29),

15. 10874674 - Crystal form of orexin receptor antagonist compound, and preparation method and application thereof (2020-12-29),

Title: Inventor Zhi Luo - Revolutionizing Technology in Shanghai

Introduction: Zhi Luo is a pioneering inventor based in Shanghai, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Zhi Luo holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Zhi Luo has worked with leading tech companies in Shanghai, driving innovation and spearheading projects that have had a significant impact on the industry.

Collaborations: Zhi Luo has collaborated with top research institutions and universities in China, fostering a culture of innovation and knowledge-sharing to push the boundaries of technological advancements.

Conclusion: Zhi Luo's dedication to pushing the boundaries of technology and his passion for innovation make him a standout figure in the inventor community, with his work continuing to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…